AGP Picks
View all

Today in Science
Provided by AGP

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 5, 2026

CTW to Announce Fiscal Year 2026 Financial Results on October 15 and Host Earnings Webinar on October 16
Oct. 5, 2026

CTW to Announce Fiscal Year 2026 Financial Results on October 15 and Host Earnings Webinar on October 16

Indeterminate GlobeNewswire
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Oct. 5, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

Indeterminate GlobeNewswire
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
Oct. 5, 2026

Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting

Indeterminate GlobeNewswire
Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army
Oct. 5, 2026

Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army

Indeterminate GlobeNewswire
iCell Gene Therapeutics Announces Upcoming Conference Presentations
Oct. 5, 2026

iCell Gene Therapeutics Announces Upcoming Conference Presentations

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
Oct. 5, 2026

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
Oct. 5, 2026

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Indeterminate GlobeNewswire
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct. 5, 2026

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
Oct. 5, 2026

BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day

Indeterminate GlobeNewswire
Environmental Toxins and Brain Health: Experts Explore Cognitive Decline, Alzheimer’s Research and Therapeutic Plasma Exchange
Oct. 5, 2026

Environmental Toxins and Brain Health: Experts Explore Cognitive Decline, Alzheimer’s Research and Therapeutic Plasma Exchange

Indeterminate GlobeNewswire
FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms
Oct. 5, 2026

FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms

Indeterminate GlobeNewswire
Financial Close Automation Enters a New Phase: 67% of UK CFOs Prioritise Account Reliability Over Speed, Sixthfin Research Finds
Oct. 5, 2026

Financial Close Automation Enters a New Phase: 67% of UK CFOs Prioritise Account Reliability Over Speed, Sixthfin Research Finds

Indeterminate GlobeNewswire
Cerene® Cryotherapy Brings Free Mother-Daughter Period Education Brunch to Indianapolis Area
Oct. 5, 2026

Cerene® Cryotherapy Brings Free Mother-Daughter Period Education Brunch to Indianapolis Area

Indeterminate GlobeNewswire
Telos Secures $13.5 Million Contract to Continue Support of Air Force Intelligence Community Cyber Operations
Oct. 5, 2026

Telos Secures $13.5 Million Contract to Continue Support of Air Force Intelligence Community Cyber Operations

Indeterminate GlobeNewswire
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Oct. 5, 2026

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Indeterminate GlobeNewswire
Baylor Genetics Selected as the Lead Sequencing Partner for Florida’s Sunshine Genetics Pilot Program Launch
Oct. 5, 2026

Baylor Genetics Selected as the Lead Sequencing Partner for Florida’s Sunshine Genetics Pilot Program Launch

Indeterminate GlobeNewswire
Frankenstein, a faithful musical film adaptation of Mary Shelley's novel streams on Prime Video and other platforms
Oct. 5, 2026

Frankenstein, a faithful musical film adaptation of Mary Shelley's novel streams on Prime Video and other platforms

Indeterminate EIN Presswire
SCWorx Corp. Announces Nasdaq Hearings Panel Grants Request for Reconsideration and Approves Continued Listing on The Nasdaq Capital Market
Oct. 5, 2026

SCWorx Corp. Announces Nasdaq Hearings Panel Grants Request for Reconsideration and Approves Continued Listing on The Nasdaq Capital Market

Indeterminate GlobeNewswire
Norsk Hydro: Update on Alunorte gas supply situation
Oct. 5, 2026

Norsk Hydro: Update on Alunorte gas supply situation

Indeterminate GlobeNewswire
Norsk Hydro: Oppdatering om gassforsyningssituasjonen ved Alunorte
Oct. 5, 2026

Norsk Hydro: Oppdatering om gassforsyningssituasjonen ved Alunorte

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.